Daily Dose - May 7th, 2024
 
 
Daily Dose | View online
 
May 7, 2024
Legislators and leaders worldwide are rapidly considering and passing regulations affecting the development and use of artificial intelligence. As more pharma executives consider using AI and begin implementing the technology, it's important that they understand how future regulations may affect their current or planned uses.
Both companies have received a 'second request' for info from the FTC regarding the proposed $16.5 billion deal — calling into question the timing of the deal's closing.
After Casgevy's historic approval as the first gene-edited cell therapy for sickle cell disease, Vertex remains busy.
Sponsored

Critical for pharmaceutical manufacturing, is to prevent the risk of instability of moisture-sensitive drugs or to prevent the risk of biological ingress of sterile parenteral drugs. Therefore, integrity tests with a high sensitivity are required. This applications report delves into test methods for container closure integrity.

Sponsored
Upholding rigorous quality standards is not only a regulatory imperative but also vital for ensuring the efficacy and safety of pharmaceutical products. And as many pharma manufacturers have discovered, enhanced quality processes can also unlock significant performance improvements.But quality improvements...